How is the EY-Parthenon Life Sciences practice?
3
Based on my personal experience, I would encourage life sciences professionals to carefully evaluate opportunities at ProcDNA before joining. I found the work to be heavily support-oriented and less strategic or innovative than I had expected. For those looking for cutting-edge analytics, consulting, data science, or technology-focused work, it may not align with your career goals. Continued in comments
I have nearly 4 years of consulting experience, 3 of those in market access consulting at a rather smaller firm in UK. I plan on shifting to Paris soon so I'm looking for exit opportunities in pharma/biotech. Any insights on which kind of roles could work for me in Franche, French language requirements and WLB (I'm practically burnt out) would be helpful to manage the move.
I've spent the last 2 years working at a smaller but well-respected healthcare/life sciences consulting firm. I've realized that A) I don't like the work of a consultant, and B) work-life balance is too important for me to continue being this miserable. 2 years of experience isn't much, but looking for advice regarding any type of roles that might see me as a good applicant? I've just hit over the 6 figure mark and am willing to take a bit of a salary cut (but not much ideally). TYIA
Anyone working at ProcDNA ? I've heard negative reviews about the company and wanted to get perspectives from current or former employees. One thing I've heard repeatedly is that company may be leveraging materials, frameworks and approaches commonly used at ZS Associates but delivering at lower cost. How accurate is this perception ? what is the reality in terms of project quality, client work, leadership and growth ? would appreciate honest feedback
I've never heard of them
Most of the partners were brought over from Navigant when leadership at EY roofied themselves one weekend and made the dumbest deal in recent history. Not a single one has any experience greater than weak market research and brand strategy - nothing remotely relevant to Big 4. Zero operations, zero deal flow, zero cost takeout, zero financial skills - just nothing. I know them all, worked with them for years. All the bodies, all the locations… PwC has the best Big 4 LS practice - and that’s a stretch. KPMG has brought over some good leads but the work is pretty much all cost takeout deal DD.
If you want to do deals or PE, it’s good. Strategy is horrible. They only really do peripherals like CRO, CDMO, etc. no true pharma strategy and also a ton of people have left the LS strategy practice in the past few months.
Honestly I have no idea. But a senior director did tell me a couple of years ago that EYP would never do true LS strategy cause they can’t ever compete with M/B in that space. Which is why they’ve always focused on pharma services. Even at peak, there were only 5-6 life science “strategy” partners and half if not more of their portfolio was deal management and/or diligence. Ever since EY bought Parthenon, they’ve continued to dilute the brand and shifted farther and farther away from strategy.